Brodalumab - AstraZeneca/Bausch Health Companies/Kyowa Kirin/LEO Pharma
At a glance
- Drug Originator Amgen
- Drug Licenced by Bausch Health Companies; Kyowa Kirin; LEO Pharma
- Drug Class Anti-inflammatories; Antiasthmatics; Antipsoriatics; Antirheumatics; Monoclonal antibodies; Skin disorder therapies
- Mechanism of Action Interleukin 17 receptor antagonists
- USA Patent Applicants VALEANT LUXEMBOURG
- USA Patents 25
- BLAs 1
- International Patents 281
Disclaimer